Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations

PURPOSE: Lung cancer is the leading cause of cancer-related mortality and non-small-cell lung cancer (NSCLC) accounts for 80–90% of all lung cancers. However, biomarkers to predict the prognosis of NSCLC patients upon treatment with tyrosine kinase inhibitors remain unreliable. Different types of EG...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Juanjuan, Tong, Sihao, Shi, Xianfeng, Wang, Chao, Xiao, Xin, Ji, Wenping, Sun, Yimian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802014/
https://www.ncbi.nlm.nih.gov/pubmed/33447080
http://dx.doi.org/10.2147/CMAR.S285121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802014/
https://www.ncbi.nlm.nih.gov/pubmed/33447080
http://dx.doi.org/10.2147/CMAR.S285121

Ejemplares similares